Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.

Preeclampsia, a severe unpredictable complication of pregnancy, occurs in 6% of pregnancies, usually in the second or third trimester. The specific etiology of preeclampsia remains unclear, although the pathophysiological hallmark of this condition appears to be an inadequate blood supply to the pla...

Full description

Bibliographic Details
Main Authors: Osnat Ashur-Fabian, Gil M Yerushalmi, Shali Mazaki-Tovi, David M Steinberg, Inbal Goldshtein, Michal Yackobovitch-Gavan, Eyal Schiff, Ninette Amariglio, Gideon Rechavi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3353943?pdf=render
_version_ 1818321528232607744
author Osnat Ashur-Fabian
Gil M Yerushalmi
Shali Mazaki-Tovi
David M Steinberg
Inbal Goldshtein
Michal Yackobovitch-Gavan
Eyal Schiff
Ninette Amariglio
Gideon Rechavi
author_facet Osnat Ashur-Fabian
Gil M Yerushalmi
Shali Mazaki-Tovi
David M Steinberg
Inbal Goldshtein
Michal Yackobovitch-Gavan
Eyal Schiff
Ninette Amariglio
Gideon Rechavi
author_sort Osnat Ashur-Fabian
collection DOAJ
description Preeclampsia, a severe unpredictable complication of pregnancy, occurs in 6% of pregnancies, usually in the second or third trimester. The specific etiology of preeclampsia remains unclear, although the pathophysiological hallmark of this condition appears to be an inadequate blood supply to the placenta. As a result of the impaired placental blood flow, intrauterine growth restriction (IUGR) and consequential fetal oxidative stress may occur. Consistent with this view, pregnancies complicated by preeclampsia and IUGR are characterized by up-regulation of key transcriptional regulators of the hypoxic response including, hif1α and as well as p53 and its target genes. Recently, the presence of circulating cell-free fetal RNA has been documented in maternal plasma. We speculated that pregnancies complicated by preeclampsia and IUGR, will be associated with an abnormal expression of p53 and/or hif1α related genes in the maternal plasma. Maternal plasma from 113 singleton pregnancies (72 normal and 41 complicated pregnancies) and 19 twins (9 normal and 10 complicated pregnancies) were collected and cell free RNA was extracted. The expression of 18 genes was measured by one step real-time RT-PCR and was analyzed for prevalence of positive/negative expression levels. Results indicate that, among the genes examined, cell free plasma expressions of p21 and hif1α were more prevalent in pregnancies complicated by hypoxia and/or IUGR (p<0.001). To conclude, we present in this manuscript data to support the association between two possible surrogate markers of hypoxia and common complications of pregnancy. More work is needed in order to implement these findings in clinical practice.
first_indexed 2024-12-13T10:42:20Z
format Article
id doaj.art-f5ed6400da7d4323a21b98a63db7f15b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T10:42:20Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f5ed6400da7d4323a21b98a63db7f15b2022-12-21T23:50:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3727310.1371/journal.pone.0037273Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.Osnat Ashur-FabianGil M YerushalmiShali Mazaki-ToviDavid M SteinbergInbal GoldshteinMichal Yackobovitch-GavanEyal SchiffNinette AmariglioGideon RechaviPreeclampsia, a severe unpredictable complication of pregnancy, occurs in 6% of pregnancies, usually in the second or third trimester. The specific etiology of preeclampsia remains unclear, although the pathophysiological hallmark of this condition appears to be an inadequate blood supply to the placenta. As a result of the impaired placental blood flow, intrauterine growth restriction (IUGR) and consequential fetal oxidative stress may occur. Consistent with this view, pregnancies complicated by preeclampsia and IUGR are characterized by up-regulation of key transcriptional regulators of the hypoxic response including, hif1α and as well as p53 and its target genes. Recently, the presence of circulating cell-free fetal RNA has been documented in maternal plasma. We speculated that pregnancies complicated by preeclampsia and IUGR, will be associated with an abnormal expression of p53 and/or hif1α related genes in the maternal plasma. Maternal plasma from 113 singleton pregnancies (72 normal and 41 complicated pregnancies) and 19 twins (9 normal and 10 complicated pregnancies) were collected and cell free RNA was extracted. The expression of 18 genes was measured by one step real-time RT-PCR and was analyzed for prevalence of positive/negative expression levels. Results indicate that, among the genes examined, cell free plasma expressions of p21 and hif1α were more prevalent in pregnancies complicated by hypoxia and/or IUGR (p<0.001). To conclude, we present in this manuscript data to support the association between two possible surrogate markers of hypoxia and common complications of pregnancy. More work is needed in order to implement these findings in clinical practice.http://europepmc.org/articles/PMC3353943?pdf=render
spellingShingle Osnat Ashur-Fabian
Gil M Yerushalmi
Shali Mazaki-Tovi
David M Steinberg
Inbal Goldshtein
Michal Yackobovitch-Gavan
Eyal Schiff
Ninette Amariglio
Gideon Rechavi
Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.
PLoS ONE
title Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.
title_full Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.
title_fullStr Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.
title_full_unstemmed Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.
title_short Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.
title_sort cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction
url http://europepmc.org/articles/PMC3353943?pdf=render
work_keys_str_mv AT osnatashurfabian cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT gilmyerushalmi cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT shalimazakitovi cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT davidmsteinberg cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT inbalgoldshtein cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT michalyackobovitchgavan cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT eyalschiff cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT ninetteamariglio cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction
AT gideonrechavi cellfreeexpressionofhif1aandp21inmaternalperipheralbloodasamarkerforpreeclampsiaandfetalgrowthrestriction